These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22655084)

  • 21. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.
    Sun J; Jiang L; Lin Y; Gerhard EM; Jiang X; Li L; Yang J; Gu Z
    Int J Nanomedicine; 2017; 12():1517-1537. PubMed ID: 28280323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
    Eldar-Boock A; Miller K; Sanchis J; Lupu R; Vicent MJ; Satchi-Fainaro R
    Biomaterials; 2011 May; 32(15):3862-74. PubMed ID: 21376390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
    Li ZB; Chen K; Chen X
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
    Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
    Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
    Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
    Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of RGD-Containing Cyclic Peptides against αvβ3 Integrin.
    Wang Y; Xiao W; Zhang Y; Meza L; Tseng H; Takada Y; Ames JB; Lam KS
    Mol Cancer Ther; 2016 Feb; 15(2):232-40. PubMed ID: 26719578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.
    Janardhanan R; Butler JT; Banik NL; Ray SK
    Brain Res; 2009 May; 1268():142-153. PubMed ID: 19285047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
    Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
    Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study.
    Kang W; Svirskis D; Sarojini V; McGregor AL; Bevitt J; Wu Z
    Oncotarget; 2017 May; 8(22):36614-36627. PubMed ID: 28402271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy.
    Feng X; Gao X; Kang T; Jiang D; Yao J; Jing Y; Song Q; Jiang X; Liang J; Chen J
    Bioconjug Chem; 2015 Aug; 26(8):1850-61. PubMed ID: 26222392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.
    Cai H; Li Z; Huang CW; Park R; Conti PS
    Curr Radiopharm; 2011 Jan; 4(1):68-74. PubMed ID: 22191616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
    Raj A; Saraf P; Javali NM; Li X; Jasti B
    J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
    Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma.
    Zhang L; Shan X; Meng X; Gu T; Guo L; An X; Jiang Q; Ge H; Ning X
    Mol Pharm; 2019 Sep; 16(9):3977-3984. PubMed ID: 31306580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
    Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R
    J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.